Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 5, 2007, Pages

  Chen, Wen Qiang ^a   Zhang, Lei ^a   Liu, Yun Fang ^a   Chen, Liang ^a   Ji, Xiao Ping ^a   Zhang, Mei ^a   Zhao, Yu Xia ^a   Yao, Gui Hua ^a   Zhang, Cheng ^a   Wang, Xing Li ^b   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Biomarkers; p53; Vulnerable plaque

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN P53; VASCULAR CELL ADHESION MOLECULE 1; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE MARKER; ECHOGRAPHY; GENE OVEREXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MEDICAL PARAMETERS; MOUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RABBIT; RUPTURE;

ANIMALS; AORTIC RUPTURE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; IMMUNOLOGIC FACTORS; MALE; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 36148981806     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00472.2007     Document Type: Article

References (38)

1. Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE. Triggering of plaque disruption and arterial thrombosis in an athersclerotic rabbit model. Circulation 91: 776-784, 1995.
2. Avanzas P, Arroyo-Espliguero R. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90: 847-852, 2004.
3. Bennett MR. Breaking the plaque: evidence for plaque rupture in animal model of atherosclerosis. Arterioscler Thromb Vasc Biol 22: 713-714, 2002.
4. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336: 1276-1282, 1997.
5. Carr SC, Farb A, Pearce WH, Virmani R, Yao JS. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 122: 757-763, 1997.
6. Chen WQ, Zhang Y, Zhang M, Ji XP, Yin Y, Zhu YF. Establishing an animal model of unstable atherosclerotic plaques. Chin Med J (Engl) 117: 1293-1298, 2004.
7. Chiesa G, Di Mario C, Colombo N, Vignati L, Marchesi M, Monteggia E, Parolini C, Lorenzon P, Laucello M, Lorusso V, Adamian M, Franceschini G, Newton R, Sirtori CR. Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis 156: 277-287, 2001.
8. Constantinides P, Chakravarti RN. Rabbit arterial thrombosis production by systemic procedures. Arch Pathol 72: 197-208, 1961.
9. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 83: 361-366, 2000.
10. De Korte CL, van der Steen AF. Characterization of plaque components and vulnerability with intravascular ultrasound elastography. Phys Med Biol 45: 1465-1475, 2000.
11. Frimerman A, Miller HI, Hallman M, Laniado S, Keren G. Intravascular ultrasound characterization of thrombi of different composition. Am J Cardiol 73: 1053-1057, 1994.
12. Ge J, Chirillo F, Schwedtmann J, Gorge G, Haude M, Baumgart D, Shah V, von Birgelen C, Sack S, Boudoulas H, Erbel R. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart 81: 621-627, 1999.
13. Gussenhoven EJ, Essed CE, Lancee CT, Mastik F, Frietman P, van Egmond FC, Reiber J, Bosch H, van Urk H, Roelandt J. Arterial wall characteristics determined by intravascular ultrasound imaging: an in vivo study. J Am Coll Cardiol 14: 947-952, 1989.
14. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, Mekori YA, Behar S. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. J Am Coll Cardiol 39: 1133-1138, 2002.
15. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154: 399-406, 2001.
16. Kawasaki M, Takatsu H, Noda T, Ito Y, Kunishima A, Arai M, Nishigaki K, Takemura G, Morita N, Minatoguchi S, Fujiwara H. Noninvasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesion using ultrasound integrated backscatter. J Am Coll Cardiol 38: 486-492, 2001.
17. Kelly P, Bhatt DL. Identification of vulnerable plaque - the quest continues. J Invasive Cardiol 19: 55-57, 2007.
18. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A in severe unstable angina. N Engl J Med 331: 417-424, 1994.
19. T) method. Methods 25: 402-408, 2001.
20. Mulvihill NT, Foley JB, Murphy RT, Curtin R, Crean PA, Walsh M. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart 85: 623-627, 2001.
21. Naghavi M, John R, Naguib S, Siadaty MS, Grasu R, Kurian KC, van Winkle WB, Soller B, Litovsky S, Madjid M, Willerson JT, Casscells W. PH heterogeneity of human and rabbit atherosclerotic plaques: a new insight into detection of vulnerable plaque. Atherosclerosis 164: 27-35, 2002.
22. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient. A call for new definition and risk assessment strategies: part I. Circulation 108: 1664-1772, 2003.
23. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96: 2955-2965, 1995.
24. Pasterkamp G, Falk E, Woutman H. Techniques characterizing the coronaryatherosclerotic plaque: Influence on clinical decision making? J Am Coll Cardiol 36: 13-21, 2000.
25. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74: 1399-1406, 1986.
26. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, Keiser JA, Ryan MJ. Animal model that mimics atherosclerotic plaque rupture. Circ Res 83: 705-713, 1998.
27. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes. An intravascular ultrasound study. Circulation 101: 598-603, 2000.
28. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the reversal of atherosclerosis with aggressive lipid lowering therapy (REVERSAL) trial. Circulation 113: 2787-2789, 2006.
29. Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 27: 705-713, 2007.
30. Takano M, Mizuno K, Takano M, Mizuno K, Okamatsu K, Yokoyama S, Ohba T, Sakai S. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 38: 99-104, 2001.
31. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Halpern EF, Bouma BE. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 107: 113-119, 2003.
32. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic and thrombotic component of human atherosclerosis in vivo. Circulation 94: 932-938, 1996.
33. Van der Wal AC, Becker AE, van der Loos CM, Das PK. The site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44, 1994.
34. Von Birgelen C, Klinkhart W, Mintz GS, Papatheodorou A, Herrmann J, Baumgart D, Haude M, Wieneke H, Ge J, Erbel R. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 37: 1864-1870, 2001.
35. -/- mice after adenovirus-mediated transfer of p53. Circulation 105: 2064-2070, 2002.
36. Waxman S, Ishibashi F, Muller JE. Detection and treatment of vulnerable plaques and vulnerable patients. Circulation 114: 2390-2411, 2006.
37. Yamagishi M, Umeno T, Hongo Y, Tsutsui H, Goto Y, Nakatani S, Miyatake K. Intravascular ultrasonic evidence for importance of plaque distribution (eccentric vs circumferential) in determining distensibility of the left anterior descending artery. Am J Cardiol 79: 1596-1600, 1997.
38. Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K, Sueishi K. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82: 147-156, 1998.